tiprankstipranks
Wave Life Sciences Pte. Ltd (WVE)
NASDAQ:WVE
US Market
WVE
Wave Life Sciences
RESEARCH TOOLSreports

Wave Life Sciences (WVE) Stock Forecast & Price Target

1,374 Followers
See the Price Targets and Ratings of:

WVE Analyst Ratings

Strong Buy
15Ratings
Strong Buy
15 Buy
0 Hold
0 Sell
Based on 15 analysts giving stock ratings to
Wave
Life Sciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

WVE Stock 12 Month Forecast

Average Price Target

$27.00
▲(276.04% Upside)
Based on 15 Wall Street analysts offering 12 month price targets for Wave Life Sciences in the last 3 months. The average price target is $27.00 with a high forecast of $52.00 and a low forecast of $13.00. The average price target represents a 276.04% change from the last price of $7.18.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","17":"$17","29":"$29","41":"$41","53":"$53"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":52,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$52.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$27.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$13.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,17,29,41,53],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.83,10.304615384615385,13.77923076923077,17.253846153846155,20.728461538461538,24.20307692307692,27.67769230769231,31.152307692307694,34.62692307692308,38.10153846153846,41.576153846153844,45.050769230769234,48.52538461538462,{"y":52,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.83,8.381538461538462,9.933076923076923,11.484615384615385,13.036153846153848,14.587692307692308,16.13923076923077,17.690769230769234,19.242307692307694,20.793846153846154,22.345384615384617,23.89692307692308,25.448461538461544,{"y":27,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.83,7.304615384615385,7.779230769230769,8.253846153846155,8.728461538461538,9.203076923076923,9.677692307692308,10.152307692307692,10.626923076923077,11.10153846153846,11.576153846153847,12.05076923076923,12.525384615384615,{"y":13,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.74,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.94,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.25,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.515,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.63,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.62,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.03,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.04,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 46, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.41,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 60, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 53, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.43,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 45, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.85,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 57, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.83,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 58, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$52.00Average Price Target$27.00Lowest Price Target$13.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on WVE
Luca Issi
RBC Capital
RBC Capital
$27→$15
Buy
108.91%
Upside
Reiterated
04/07/26
Wave Life Sciences price target lowered to $15 from $27 at RBC CapitalWave Life Sciences price target lowered to $15 from $27 at RBC Capital
Wells Fargo Analyst forecast on WVE
Benjamin Burnett
Wells Fargo
Wells Fargo
$23→$13
Buy
81.06%
Upside
Reiterated
04/01/26
Wave Life Sciences (WVE) Receives a Buy from Wells Fargo
Wedbush Analyst forecast on WVE
Yun Zhong
Wedbush
Wedbush
$35→$15
Buy
108.91%
Upside
Assigned
03/27/26
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (NYSE: ABT), Pfizer (NYSE: PFE) and Wave Life Sciences (NASDAQ: WVE)
Leerink Partners Analyst forecast on WVE
Joseph Schwartz
Leerink Partners
Leerink Partners
$35→$25
Buy
248.19%
Upside
Reiterated
03/26/26
Leerink says Wave Life Sciences selloff 'very overdone' after early obesity dataLeerink says Wave Life Sciences selloff 'very overdone' after early obesity data
JonesTrading Analyst forecast on WVE
Catherine Novack
JonesTrading
JonesTrading
$35
Buy
387.47%
Upside
Reiterated
03/26/26
Wave Life may not be competitive against GLP-1s, says JonesResearchWave Life may not be competitive against GLP-1s, says JonesResearch
Clear Street Analyst forecast on WVE
William Maughan
Clear Street
Clear Street
$50→$39
Buy
443.18%
Upside
Reiterated
03/26/26
Wave Life Sciences price target lowered to $39 from $50 at Clear StreetWave Life Sciences price target lowered to $39 from $50 at Clear Street
Bank of America Securities Analyst forecast on WVE
Alec Stranahan
Bank of America Securities
Bank of America Securities
$38→$21
Buy
192.48%
Upside
Reiterated
03/26/26
Risk-Adjusted Buy Rating on Wave Life Sciences: Differentiated Obesity Mechanism, Reset Valuation, and Long-Term Upside Despite 400 mg Uncertainty
Jefferies Analyst forecast on WVE
Roger Song
Jefferies
Jefferies
$28→$18
Buy
150.70%
Upside
Assigned
03/26/26
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (NASDAQ: WVE) and Kodiak Sciences (NASDAQ: KOD)
Mizuho Securities Analyst forecast on WVE
Salim Syed
Mizuho Securities
Mizuho Securities
$22→$27
Buy
276.04%
Upside
Reiterated
03/24/26
Mizuho Securities Reaffirms Their Buy Rating on Wave Life Sciences (WVE)
Canaccord Genuity Analyst forecast on WVE
Whitney Ijem
Canaccord Genuity
Canaccord Genuity
$43→$52
Buy
624.23%
Upside
Reiterated
03/10/26
Wave Life Sciences price target raised to $52 from $43 at CanaccordWave Life Sciences price target raised to $52 from $43 at Canaccord
Citi Analyst forecast on WVE
Samantha Semenkow
Citi
Citi
$30
Buy
317.83%
Upside
Reiterated
03/06/26
Citi opens 'upside 30-day catalyst watch' on Wave Life SciencesCiti opens 'upside 30-day catalyst watch' on Wave Life Sciences
H.C. Wainwright Analyst forecast on WVE
Andrew Fein
H.C. Wainwright
H.C. Wainwright
$30
Buy
317.83%
Upside
Reiterated
03/02/26
Wave Life Sciences: Differentiated Obesity Franchise and RNA-Editing Pipeline Momentum Justify Buy Rating
Truist Financial Analyst forecast on WVE
Joon Lee
Truist Financial
Truist Financial
―
Buy
―
Reiterated
02/27/26
Analysts Offer Insights on Healthcare Companies: Teleflex (NYSE: TFX), Progyny (NASDAQ: PGNY) and Wave Life Sciences (NASDAQ: WVE)
Oppenheimer Analyst forecast on WVE
Cheng Li
Oppenheimer
Oppenheimer
$32
Buy
345.68%
Upside
Reiterated
02/27/26
Analysts Offer Insights on Healthcare Companies: Catalyst Pharma (NASDAQ: CPRX) and Wave Life Sciences (NASDAQ: WVE)
Raymond James Analyst forecast on WVE
Martin Auster
Raymond James
Raymond James
$13.87→$26
Buy
262.12%
Upside
Reiterated
01/13/26
Wave Life Sciences (WVE) Receives a Buy from Raymond James
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on WVE
Luca Issi
RBC Capital
RBC Capital
$27→$15
Buy
108.91%
Upside
Reiterated
04/07/26
Wave Life Sciences price target lowered to $15 from $27 at RBC CapitalWave Life Sciences price target lowered to $15 from $27 at RBC Capital
Wells Fargo Analyst forecast on WVE
Benjamin Burnett
Wells Fargo
Wells Fargo
$23→$13
Buy
81.06%
Upside
Reiterated
04/01/26
Wave Life Sciences (WVE) Receives a Buy from Wells Fargo
Wedbush Analyst forecast on WVE
Yun Zhong
Wedbush
Wedbush
$35→$15
Buy
108.91%
Upside
Assigned
03/27/26
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (NYSE: ABT), Pfizer (NYSE: PFE) and Wave Life Sciences (NASDAQ: WVE)
Leerink Partners Analyst forecast on WVE
Joseph Schwartz
Leerink Partners
Leerink Partners
$35→$25
Buy
248.19%
Upside
Reiterated
03/26/26
Leerink says Wave Life Sciences selloff 'very overdone' after early obesity dataLeerink says Wave Life Sciences selloff 'very overdone' after early obesity data
JonesTrading Analyst forecast on WVE
Catherine Novack
JonesTrading
JonesTrading
$35
Buy
387.47%
Upside
Reiterated
03/26/26
Wave Life may not be competitive against GLP-1s, says JonesResearchWave Life may not be competitive against GLP-1s, says JonesResearch
Clear Street Analyst forecast on WVE
William Maughan
Clear Street
Clear Street
$50→$39
Buy
443.18%
Upside
Reiterated
03/26/26
Wave Life Sciences price target lowered to $39 from $50 at Clear StreetWave Life Sciences price target lowered to $39 from $50 at Clear Street
Bank of America Securities Analyst forecast on WVE
Alec Stranahan
Bank of America Securities
Bank of America Securities
$38→$21
Buy
192.48%
Upside
Reiterated
03/26/26
Risk-Adjusted Buy Rating on Wave Life Sciences: Differentiated Obesity Mechanism, Reset Valuation, and Long-Term Upside Despite 400 mg Uncertainty
Jefferies Analyst forecast on WVE
Roger Song
Jefferies
Jefferies
$28→$18
Buy
150.70%
Upside
Assigned
03/26/26
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (NASDAQ: WVE) and Kodiak Sciences (NASDAQ: KOD)
Mizuho Securities Analyst forecast on WVE
Salim Syed
Mizuho Securities
Mizuho Securities
$22→$27
Buy
276.04%
Upside
Reiterated
03/24/26
Mizuho Securities Reaffirms Their Buy Rating on Wave Life Sciences (WVE)
Canaccord Genuity Analyst forecast on WVE
Whitney Ijem
Canaccord Genuity
Canaccord Genuity
$43→$52
Buy
624.23%
Upside
Reiterated
03/10/26
Wave Life Sciences price target raised to $52 from $43 at CanaccordWave Life Sciences price target raised to $52 from $43 at Canaccord
Citi Analyst forecast on WVE
Samantha Semenkow
Citi
Citi
$30
Buy
317.83%
Upside
Reiterated
03/06/26
Citi opens 'upside 30-day catalyst watch' on Wave Life SciencesCiti opens 'upside 30-day catalyst watch' on Wave Life Sciences
H.C. Wainwright Analyst forecast on WVE
Andrew Fein
H.C. Wainwright
H.C. Wainwright
$30
Buy
317.83%
Upside
Reiterated
03/02/26
Wave Life Sciences: Differentiated Obesity Franchise and RNA-Editing Pipeline Momentum Justify Buy Rating
Truist Financial Analyst forecast on WVE
Joon Lee
Truist Financial
Truist Financial
―
Buy
―
Reiterated
02/27/26
Analysts Offer Insights on Healthcare Companies: Teleflex (NYSE: TFX), Progyny (NASDAQ: PGNY) and Wave Life Sciences (NASDAQ: WVE)
Oppenheimer Analyst forecast on WVE
Cheng Li
Oppenheimer
Oppenheimer
$32
Buy
345.68%
Upside
Reiterated
02/27/26
Analysts Offer Insights on Healthcare Companies: Catalyst Pharma (NASDAQ: CPRX) and Wave Life Sciences (NASDAQ: WVE)
Raymond James Analyst forecast on WVE
Martin Auster
Raymond James
Raymond James
$13.87→$26
Buy
262.12%
Upside
Reiterated
01/13/26
Wave Life Sciences (WVE) Receives a Buy from Raymond James
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Wave Life Sciences

3 Months
xxx
Success Rate
9/19 ratings generated profit
47%
Average Return
+15.29%
reiterated a xxx
 rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 47.37% of your transactions generating a profit, with an average return of +15.29% per trade.
1 Year
Joseph SchwartzLeerink Partners
Success Rate
16/19 ratings generated profit
84%
Average Return
+43.30%
reiterated a buy rating 17 days ago
Copying Joseph Schwartz's trades and holding each position for 1 Year would result in 84.21% of your transactions generating a profit, with an average return of +43.30% per trade.
2 Years
xxx
Success Rate
15/19 ratings generated profit
79%
Average Return
+80.59%
reiterated a xxx
 rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 78.95% of your transactions generating a profit, with an average return of +80.59% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WVE Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
26
19
24
26
24
Buy
11
13
17
8
5
Hold
60
53
45
57
58
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
97
85
86
91
87
In the current month, WVE has received 29 Buy Ratings, 58 Hold Ratings, and 0 Sell Ratings. WVE average Analyst price target in the past 3 months is 27.00.
Each month's total comprises the sum of three months' worth of ratings.

WVE Financial Forecast

WVE Earnings Forecast

Next quarter’s earnings estimate for WVE is -$0.32 with a range of -$0.38 to -$0.25. The previous quarter’s EPS was -$0.30. WVE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year WVE has Performed in-line its overall industry.
Next quarter’s earnings estimate for WVE is -$0.32 with a range of -$0.38 to -$0.25. The previous quarter’s EPS was -$0.30. WVE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year WVE has Performed in-line its overall industry.

WVE Sales Forecast

Next quarter’s sales forecast for WVE is $8.45M with a range of $0.00 to $18.00M. The previous quarter’s sales results were $17.25M. WVE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year WVE has Performed in-line its overall industry.
Next quarter’s sales forecast for WVE is $8.45M with a range of $0.00 to $18.00M. The previous quarter’s sales results were $17.25M. WVE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year WVE has Performed in-line its overall industry.

WVE Stock Forecast FAQ

What is WVE’s average 12-month price target, according to analysts?
Based on analyst ratings, Wave Life Sciences Pte. Ltd’s 12-month average price target is 27.00.
    What is WVE’s upside potential, based on the analysts’ average price target?
    Wave Life Sciences Pte. Ltd has 276.04% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is WVE a Buy, Sell or Hold?
          Wave Life Sciences Pte. Ltd has a consensus rating of Strong Buy which is based on 15 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Wave Life Sciences Pte. Ltd’s price target?
            The average price target for Wave Life Sciences Pte. Ltd is 27.00. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $52.00 ,the lowest forecast is $13.00. The average price target represents 276.04% Increase from the current price of $7.18.
              What do analysts say about Wave Life Sciences Pte. Ltd?
              Wave Life Sciences Pte. Ltd’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
                How can I buy shares of WVE?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.